CMILF yields 2628.12% · PFE yields 6.13%● Live data
📍 CMILF pulled ahead of the other in Year 1
Combined, CMILF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CMILF + PFE for your $10,000?
Capella Minerals Limited, together with its subsidiaries, engages in the acquisition, exploration, and evaluation of mineral properties in Canada. It primarily explores for gold, copper, and lithium deposits, as well as for silver and zinc deposits. The company holds 100% interests in the Southern Gold Line project in Sweden; Hessjøgruva Project located in the northern Røros Mining District, Norway; Vaddas-Birtavarre Copper-Cobalt project in northern Norway; and Kjøli and Løkken Project in the Trøndelag County. It also holds interests in the Domain, Manitoba, and Savant Lake projects in Ontario, Canada; Aakenus-Katajavaara project in northern Finland; Perho project located in Southern Finland; and Sierra Blanca Gold-Silver Project in Santa Cruz, Argentina. The company was formerly known as New Dimension Resources Ltd. and changed its name to Capella Minerals Limited in November 2020. Capella Minerals Limited was incorporated in 2005 and is based in Mission, Canada.
Full CMILF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.